miR-340 Predicts Glioblastoma Survival and Modulates Key Cancer Hallmarks Through Down-Regulation of NRAS
Oncotarget - United States
doi 10.18632/oncotarget.6968
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 21, 2016
Authors
Publisher
Impact Journals, LLC